Back
Edwards Lifesciences Quote, Financials, Valuation and Earnings

Take advantage of the biggest IPO in history
Click here to see more
Sell
28
EW
Edwards Lifesciences
Last Price:
76.35
Seasonality Move:
-0.09%
7 Day Trial
ALL ACCESS PASS
$
7

Is Elon Musk right about AI?
Learn all about it here.Edwards Lifesciences Price Quote
$76.35
-0.03 (-0.16%)
(Updated: September 2, 2023 at 6:10 AM ET)
Edwards Lifesciences Key Stats
Sell
28
Edwards Lifesciences (EW)
is a Sell
Day range:
$75.85 - $77.20
52-week range:
$67.13 - $98.35
Dividend yield:
0%
P/E ratio:
31.30
P/S ratio:
8.31
P/B ratio:
7.28%
Volume:
2.4M
Avg. volume:
3.6M
1-year change:
-15.25%
Market cap:
$46.4B
Revenue:
$5.4B
EPS:
$2.26
How Much Does Edwards Lifesciences Make?
-
How Much Are Edwards Lifesciences's Sales Annually?
EW Revenues are $5.4B -
How Much Profit Does Edwards Lifesciences's Make A Year?
EW net income is $1.5B
Is Edwards Lifesciences Growing As A Company?
-
What Is Edwards Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.11% -
What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.23%
Edwards Lifesciences Stock Price Performance
-
Did Edwards Lifesciences Stock Go Up Last Month?
Edwards Lifesciences share price went down by -6.91% last month -
Did EW's Share Price Rise Over The Last Year?
EW share price fell by -15.25% over the past 1 year
What Is Edwards Lifesciences 52-Week High & Low?
-
What Is Edwards Lifesciences’s 52-Week High Share Price?
Edwards Lifesciences has traded as high as $98.35 over the past 52 weeks -
What Is Edwards Lifesciences’s 52-Week Low Share Price?
Edwards Lifesciences has traded as low as $67.13 over the past 52 weeks
Edwards Lifesciences Price To Free Cash Flow
-
Is Edwards Lifesciences Stock Overvalued?
Edwards Lifesciences is trading at a price to free cash flow ratio of 68.93 -
Is Edwards Lifesciences Stock Undervalued?
Edwards Lifesciences EV to Free Cash Flow ratio is 66.85 -
What Is Edwards Lifesciences’s Price Earnings Growth Ratio?
EW PEG ratio is 0.00 -
Is Edwards Lifesciences Trading At A Premium To Earnings?
Edwards Lifesciences EV to EBIT ratio is 25.62
Is It Risky To Buy Edwards Lifesciences?
-
How Much Debt Does Edwards Lifesciences Have?
Total long term debt quarterly is $596.7M -
How Much Cash Does Edwards Lifesciences Have?
Cash and short term investments quarterly total is $1.5B -
What Is Edwards Lifesciences’s Book Value Per Share?
Book value per share is 10.49
Is Edwards Lifesciences Cash Flow Positive?
-
What Is EW Cash Flow From Operations?
Cash flow from operations (TTM) is $940.4M -
What Is Edwards Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.1B -
What Is Edwards Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$36.1M
Edwards Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
EW return on invested capital is 20.77% -
What Is Edwards Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is 16.15% -
What Is EW Return On Equity?
ROE is a measure of profitability and is 22.91%
Edwards Lifesciences Earnings Date & Stock Price
-
What Is Edwards Lifesciences's Stock Price Today?
A single share of EW can be purchased today for 76.38 -
What Is Edwards Lifesciences’s Stock Symbol?
Edwards Lifesciences trades on the S&P500 under the ticker symbol: EW -
When Is Edwards Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Edwards Lifesciences is scheduled on October 27, 2023 -
When Is EW's next ex-dividend date?
Edwards Lifesciences's next ex-dividend date is September 4, 2023 -
How To Buy Edwards Lifesciences Stock?
You can buy Edwards Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Edwards Lifesciences Competitors
-
Who Are Edwards Lifesciences's Competitors?
Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
Edwards Lifesciences Dividend Yield
Data Unavailable
Edwards Lifesciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -23.08% | 1.89% |
Revenue: | 11.38% | 1.67% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 14 |
Sell Recommendations: | 0 |
Price Target: | 96.09 |
Upside from Last Price: | 25.8% |